Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: A multicenter phase 2 study
Titel:
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: A multicenter phase 2 study
Auteur:
Kater, Arnon P. Spiering, Marjolein Liu, Roberto D. Doreen te Raa, G. Slinger, E. Tonino, Sanne H. Beckers, Marielle M. Daenen, Simon Doorduijn, Jeanette K. Lankheet, Nienke A.G. Luijks, Dieuwertje M. Eldering, Eric van Oers, Marinus H.J.